The characterization of chronic rhinosinusitis in hospitalized patients with COVID-19

J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3597-3599.e2. doi: 10.1016/j.jaip.2020.09.013. Epub 2020 Sep 24.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / epidemiology
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Betacoronavirus
  • COVID-19
  • China / epidemiology
  • Chronic Disease
  • Comorbidity
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / physiopathology
  • Coronavirus Infections / therapy
  • Female
  • Glucocorticoids / therapeutic use
  • Hospitalization
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Factors / therapeutic use
  • Liver Diseases / epidemiology
  • Male
  • Middle Aged
  • Oxygen Inhalation Therapy
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / physiopathology
  • Pneumonia, Viral / therapy
  • Respiration, Artificial
  • Respiratory Distress Syndrome / epidemiology
  • Rhinitis / epidemiology*
  • Risk Factors
  • SARS-CoV-2
  • Severity of Illness Index
  • Shock / epidemiology
  • Sinusitis / epidemiology*

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents
  • Glucocorticoids
  • Immunoglobulins, Intravenous
  • Immunologic Factors